Ishtiyaq Ahmad
Srinagar, Sep 11 : With the administration of 65,27,175 vaccine doses in the last 24 hours, the officials said that India’s COVID-19 vaccination coverage surpassed the figure of 73Cr landmark milestone (73,05,89,688).
One of the top officials in the health department said that the Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.
“The recovery of 32,198patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,23,74,497. Consequently, India’s recovery rate stands at 97.49%,” the official said.
He said that sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 76 consecutive days now.
“33,376new cases were reported in the last 24 hours. The Active Caseload is presently 3,91,516. Active cases presently constitute 1.18% of the country’s total Positive Cases”.
He told KINS that the testing capacity across the country continues to be expanded. “The last 24 hours saw a total of 15,92,135tests being conducted. India has so far conducted over 54.01 Cr (54,01,96,989) cumulative tests,”.
“While testing capacity has been enhanced across the country, the Weekly Positivity Rate at 2.26% remains less than 3% for the last 78 days now. The Daily Positivity rate reported to be2.10%. The daily Positivity rate has remained below3% for the last 12 days and below 5% for 96 consecutive days now.”
Meanwhile as per the government update more than 5.75 Crore balance and unutilized vaccine doses still available with States/UTs
“The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain,” the government has informed.
“As part of the nationwide vaccination drive, the Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs”.
“More than 72.01crore (72,01,73,325) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category. While more than 5.75Cr (5,75,43,795) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
It is to be mentioned here that PM Narendra Modi chaired a high level meeting to review the Covid-19 related situation yesterday.
The topics covered included a review of the prevailing Covid-19 scenario, preparedness of the health systems to respond, availability of medical oxygen and matters relating to production, supply and distribution of Covid-19 vaccine.
It was discussed that across the world, there are countries where the number of active Covid cases continues to remain high. In India too, the figures from states like Maharashtra & Kerala, indicate that there can be no room for complacency. However, the weekly positivity was at less than 3% for the 10th consecutive week.
The PM was briefed about the concentration of cases in a few geographies, districts with high test positivity as well as the week on week test positivity rate in the country.
PM spoke about the need for constant genome sequencing to monitor emergence of mutants. The officers informed him that INSACOG now consists of 28 labs distributed across the country. The lab network is also linked with a hospital network for clinical correlation. Sewage sampling is also being done for genomic surveillance. PM was apprised that states have been requested to share SARS COV2 positive samples with INSACOG regularly.(KINS)
